Identification and evaluation of besifloxacin as repurposed antifungal drug in combination with fluconazole against Candida albicans
Shuvechha Chakraborty, Ameya Pawaskar, Siddhanath Metkari, Taruna Madan, Susan Idicula‐Thomas
This study identifies besifloxacin as a repurposed antifungal drug that synergizes with fluconazole to inhibit Candida albicans growth and reduce fungal load in mice.
Chemical Biology & Drug Design · Jun 1, 2025Peer-reviewedMicrobiology